Welcome to LookChem.com Sign In|Join Free

CAS

  • or
palmarumycin CP(1) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

159933-90-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 159933-90-1 Structure
  • Basic information

    1. Product Name: palmarumycin CP(1)
    2. Synonyms: palmarumycin CP(1)
    3. CAS NO:159933-90-1
    4. Molecular Formula: C20H12O4
    5. Molecular Weight: 316.30688
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 159933-90-1.mol
  • Chemical Properties

    1. Melting Point: 171-172 °C
    2. Boiling Point: 602.1°Cat760mmHg
    3. Flash Point: 226.8°C
    4. Appearance: /
    5. Density: 1.5g/cm3
    6. Vapor Pressure: 4.3E-15mmHg at 25°C
    7. Refractive Index: 1.78
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. PKA: 7.16±0.20(Predicted)
    11. CAS DataBase Reference: palmarumycin CP(1)(CAS DataBase Reference)
    12. NIST Chemistry Reference: palmarumycin CP(1)(159933-90-1)
    13. EPA Substance Registry System: palmarumycin CP(1)(159933-90-1)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 159933-90-1(Hazardous Substances Data)

159933-90-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 159933-90-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,9,3 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 159933-90:
(8*1)+(7*5)+(6*9)+(5*9)+(4*3)+(3*3)+(2*9)+(1*0)=181
181 % 10 = 1
So 159933-90-1 is a valid CAS Registry Number.
InChI:InChI=1/C20H12O4/c21-14-7-3-6-13-19(14)15(22)10-11-20(13)23-16-8-1-4-12-5-2-9-17(24-20)18(12)16/h1-11,21H

159933-90-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name Palmarumycin CP(1)

1.2 Other means of identification

Product number -
Other names 5-hydroxyspiro[naphthalene-1,2'-naphtho[1,8-de][1,3]dioxin]-4-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:159933-90-1 SDS

159933-90-1Downstream Products

159933-90-1Relevant articles and documents

Synthesis and biological evaluation of deoxypreussomerin A and palmarumycin CP1 and related naphthoquinone spiroketals

Wipf, Peter,Jung, Jae-Kyu,Rodríguez, Sonia,Lazo, John S

, p. 283 - 296 (2001)

Oxidative cyclization of bis-hydroxynaphthyl ethers allows concise total syntheses of palmarumycin CP1 and deoxypreussomerin A in 8-9 steps and 15-35% overall yield from 5-hydroxy-8-methoxy-1-tetralone (8). Polymer-bound triphenyl phosphine was found to be a superior reagent for the rapid preparation of a small library of palmarumycin analogs. Preliminary biological evaluation of naphthoquinone spiroketals against MCF-7 and MDA-MB-231 human breast cancer cells revealed several low-micromolar growth inhibitors.

The synthesis of 1,8-dihydroxynaphthalene-derived natural products: Palmarumycin CP1, palmarumycin CP2, palmarumycin C11, CJ-12,371, deoxypreussomerin a and novel analogues

Ragot, Jacques P.,Steeneck, Christoph,Alcaraz, Marie-Lyne,Taylor, Richard J. K.

, p. 1073 - 1082 (1999)

Total syntheses of the title fungal metabolites are described via a route which utilises initial acetalisation with 1,8-dihydroxynaphthalene followed by elaboration of the ring A functionality. Novel analogues are also reported. Structural clarification is provided for palmarumycin CM, bipendensin and Sch 53,823.

Syntheses of palmarumycin CP1 and CP2, CJ-12,371 and novel analogues

Ragot, Jacques P.,Alcaraz, Marie-Lyne,Taylor, Richard J. K.

, p. 4921 - 4924 (1998)

Total syntheses of the title fungal metabolites are described via a route which utilises initial acetalisation with 1,8-dihydroxynaphthalene followed by elaboration of the ring A functionality. Novel analogues are also reported.

Total syntheses of palmarumycins CP1 and CP2 and CJ-12,371: Novel spiro-ketal fungal metabolites

Barrett, Anthony G.M.,Hamprecht, Dieter,Meyer, Thorsten

, p. 809 - 810 (1998)

Total syntheses of palmarumycins CP1 1 and CP2 9 and the structurally related CJ-12,371 11 are reported, thereby establishing a strategy for the synthesis of further natural products in the palmarumycins, diepoxines and preussomerines family.

Total synthesis of Palmarumycin BGs, C1 and Guignardin e

Liu, Xinlei,Li, Shuyi,Wei, Xinyu,Zhao, Yu,Lai, Daowan,Zhou, Ligang,Wang, Mingan

, p. 1588 - 1594 (2020/01/25)

The first total synthesis of Palmarumycin BG1-3, BG5-6, C1 and Guignardin E (1-7) were achieved by the same intermediate Palmarumycin C2 through a N-benzyl cinchoninium chloride-catalyzed epoxidation, an organoselenium-mediated reduction, and a cerium(iii) chloride hydrate-promoted regioselective ring-opening and elimination of cyclic α,β-epoxy ketone as the key steps via6-7 step routes using 1,8-dihydroxynaphthalene (DHN) and 5-methoxytetralone as the starting materials in overall yields of 1.0-17.4%, respectively. Their structures and absolute configurations were characterized and determined by 1H, 13C NMR, IR, HR-ESI-MS and X-ray diffraction data. These compounds displayed significant inhibition activities against HCT116, U87-MG, HepG2, BGC823 and PC9 cell lines.

Flexible route to palmarumycin CP1and CP2and CJ-12.371 methyl ether

Krohn, Karsten,Wang, Si,Ahmed, Ishtiaq,Altun, Sultan,Asian, Abdulselam,Floerke, Ulrich,Kock, Ines,Schlummer, Stefanie

experimental part, p. 4476 - 4481 (2010/10/02)

The total synthesis of palmarumycin CP1 (4) and CP2 (5) and racemic CJ-12.371 methyl ether (17) is described using the Diels-Alder reaction of benzoquinone 1,8-dihydroxynaphthalene acetal (10) with l-methoxy-1,3-butadiene under neat

Unified route to the palmarumycin and preussomerin natural products. Enantioselective synthesis of (-)-preussomerin G

Barrett, Anthony G.M.,Blaney, Frank,Campbell, Andrew D.,Hamprecht, Dieter,Meyer, Thorsten,White, Andrew J.P.,Witty, David,Williams, David J.

, p. 2735 - 2750 (2007/10/03)

The total syntheses of eight members of the palmarumycin family have been achieved, with identification of the absolute stereochemistry for three of these natural products. In addition, the ras-farnesyl transferase inhibitor (-)-preussomerin G has been synthesized, achieving the first enantioselective route for accessing this family of natural products. Highlights of the synthetic work include an asymmetric epoxidation of a cyclic enone in excellent yield and enantiomeric excess and a potentially biomimetic oxidative spirocyclization for the introduction of the bis-spiroketal array unique to the preussomerin natural products.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 159933-90-1